6 Taft Court Suite 100
Rockville, MD 20850
OriGene Technologies was founded in 1997 as a research tool company focused upon the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete sequence of the human genome and the subsequent development of genome-based tools has enabled the identification of relevant drug targets through system biology approaches. OriGene's vision has been to prepare for the approach of these systematic biology methods by creating comprehensive cDNA clone collections and related technologies and applications for gene function analysis. These collections, technologies and applications will enable scientists to look at full, biologically relevant networks to best understand disease mechanisms.
TissueScan qPCR Array: Biomarker Validation via Gene Expression Profiling in a Large Number of Tumors